UK markets closed

Delcath Systems, Inc. (DCTH)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.7700-0.3200 (-6.29%)
At close: 04:00PM EDT
4.8700 +0.10 (+2.10%)
After hours: 07:16PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close5.0900
Open5.0300
Bid4.7700 x 400
Ask4.8300 x 400
Day's range4.7600 - 5.0500
52-week range2.2500 - 7.9900
Volume393,020
Avg. volume221,316
Market cap109.341M
Beta (5Y monthly)0.51
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • PR Newswire

    Delcath Systems Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update

    Delcath Systems, Inc. (Nasdaq: DCTH) ("Delcath" or the "Company"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today reported recent business highlights and financial results for the fourth quarter and full year ended December 31, 2023.

  • PR Newswire

    Delcath Systems Closes $7 Million Private Placement

    Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, confirmed the closing of the previously announced private placement with certain accredited investors comprised of existing investors, Delcath Executives and members of its Board of Directors, for a private placement transaction (the "Private Placement").

  • PR Newswire

    Delcath Systems to Host Fourth Quarter and Full Year 2023 Results and Business Update Call

    Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today it will host a conference call on March 26, 2024, at 8:30 AM Eastern Time to discuss results for its fourth quarter and year ended December 31, 2023 and provide a business update.